Fluorescein 0.25% / Benoxinate 0.4% · ophthalmic solution
Diagnostic Dye, Local Anesthetic
Approved uses
Ophthalmic procedures requiring a disclosing agent with topical anesthesia
1 to 2 drops in the eye as needed to achieve adequate anesthesia; the anesthetic effect may be extended by repeat instillation 10 to 20 minutes after the last dose
Maximal corneal anesthesia in 5 to 45 seconds, lasting about 20 minutes after a single instillation.
Contraindications
Known hypersensitivity to any component of this product.
Fluorescein sodium 0.25% (2.5 mg/mL) with benoxinate HCl 0.4% (4 mg/mL) ophthalmic solution, 5 mL glass bottle with sterilized dropper
Combination of a disclosing dye with a rapidly acting ester anesthetic of short duration: fluorescein is excluded by an intact epithelial barrier and fluoresces green under cobalt blue excitation, while benoxinate blocks sodium channel conduction in corneal and conjunctival sensory nerve endings. Maximal corneal anesthesia usually occurs in about 5 to 45 seconds and lasts about 20 minutes after a single instillation.
Warnings & Precautions
- Corneal toxicity: Prolonged use or abuse may lead to corneal epithelial toxicity, which may manifest as epithelial defects and progress to permanent corneal opacification with accompanying visual loss.
- Corneal injury due to insensitivity: The patient should not touch the eye for approximately 20 minutes after using this anesthetic, as accidental injuries can occur due to insensitivity of the eye.
- Anesthetic abuse keratopathy: Case reports of oxybuprocaine (benoxinate) abuse describe chronic epithelial defects with stromal infiltration, one at a concentration of 0.05% used every 5 to 10 minutes, and one patient who underwent penetrating keratoplasty with thinning of the central stroma and damage to endothelial cell attachments.
- Solution contamination: All 21 in-use multiple-use fluorescein bottles from eye clinics in Ghana had positive cultures, most often Pseudomonas spp., while eighteen unopened bottles had none. In separate laboratory inoculation studies, Pseudomonas disappeared from a chlorobutanol-preserved fluorescein-benoxinate solution within 15 seconds, and no organisms could be cultured from Fluress one minute after inoculation, while other fluorescein-anesthetic preparations still grew organisms for at least one hour.
- Soft contact lens staining: In a spectrophotometric laboratory study of hydrophilic lenses, absorption of fluorescein into the lens matrix was proportional to exposure time and depended on the optical power and water content of the lens. 0.9% saline appeared preferable to oxidizing agents as a rinsing solution, and 3% hydrogen peroxide solution made the fluorescein colorless while it was still retained within the lens.
Common Side Effects
The most common ocular adverse events are stinging, burning, and conjunctival redness. Ocular hyperemia, eye irritation, blurred vision, and punctate keratitis have also been reported voluntarily from a population of uncertain size, so it is not always possible to reliably estimate their frequency.
Pregnancy: No data in pregnant women, and adequate animal reproduction studies have not been conducted for either component; give only if clearly needed.
Lactation: No data on presence in human milk, on the breastfed infant, or on milk production.
Established in pediatric patients, supported by evidence from adequate and well controlled studies.